Soleus Capital Management, L.P. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,035,631
+288.0%
4,134,868
+313.5%
0.42%
+180.5%
Q4 2022$1,040,000
-78.1%
1,000,000
-75.8%
0.15%
-76.9%
Q3 2022$4,755,000
-38.5%
4,134,8680.0%0.65%
-46.4%
Q2 2022$7,732,000
-38.3%
4,134,8680.0%1.21%
-25.4%
Q1 2022$12,529,000
+382.3%
4,134,868
+501.5%
1.62%
+521.5%
Q4 2021$2,598,000
-32.1%
687,412
-7.1%
0.26%
-56.4%
Q3 2021$3,826,000
+197.7%
740,000
+48.0%
0.60%
+156.9%
Q1 2021$1,285,000
+2.8%
500,0000.0%0.23%
+40.6%
Q4 2020$1,250,000
+20.8%
500,0000.0%0.16%
-69.9%
Q3 2020$1,035,000500,0000.55%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders